Showing 751-760 of 4705 results for "".
A Nose for Disease: A Review of Olfactory-Based Diagnosis in Dermatology
https://practicaldermatology.com/topics/infections-infectious-disease/a-nose-for-disease-a-review-of-olfactory-based-diagnosis-in-dermatology/23650/Despite technological advancements in diagnosis, the sense of smell can still be a helpful tool in the medical clinic.Prescribing Pitfalls, Part I: Navigate the Changing Landscape of Brand Name Drug Prescribing
https://practicaldermatology.com/topics/practice-management/prescribing-pitfalls-part-i-navigate-the-changing-landscape-of-brand-name-drug-prescribing/21440/Prescribers increasingly need to understand drug pricing, pharmacy policies, insurance coverage, and coupon offers to ensure patients get the medications they need.Advanced Systemic Therapeutics
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advanced-systemic-therapeutics/18755/By Seemal R. Desai, MD and Neal Bhatia, MD, FAADFrom updates in infectious disease to hormonal therapies, and off-label uses of biologics, the key to successful treatment is matching mechanisms to disease states. Dr. Bhatia explains.Topical Treatment Considerations for Psoriasis
https://practicaldermatology.com/topics/psoriasis/topical-treatment-considerations-for-psoriasis/18845/Jerry Bagel, MD and Neil J. Korman, MD discuss topical treatment options for treating patients with mild psoriasis. They share insights about the effect of vehicles on compliance, particularly when treating patients with scalp psoriasis.Clinical Conversations: How JAK Inhibitors are Changing the AD Treatment Landscape
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-how-jak-inhibitors-are-changing-the-ad-treatment-landscape/20092/With the approval of JAK inhibitors to treat eczema, the treatment landscape is changing. Matt Zirwas, MD and Adelaide Hebert, MD talk about the role for JAK inhibitors and key considerations for discussing options with patients.Effective Patient Consultations: Keys to Success
https://practicaldermatology.com/topics/practice-management/effective-patient-consultations-keys-to-success/20122/So much depends on the patient consultation, and its key that all members of the practice staff are attentive to the needs of the patient and the practice. Amy Lewis, MD and Mark Rubin, MD weigh in on strategies for effective patient interactions.Update on Keloids and Scarring
https://practicaldermatology.com/topics/general-topics/update-on-keloids-and-scarring/19267/Brian Berman, MD talks with host Joshua Zeichner, MD about the use of interferon and topical immune modulators for the management of keloids. What does the evidence show? What are optimal protocols?Approaches to AK Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/approaches-to-ak-management/20133/When confronted with AK, dermatologists are armed with various treatment options, including destructive and field-directed therapies. Vishal Patel, MD and Neal Bhatia, MD talk about their approach to decision-making.Skin Checks and Patient Education on Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-checks-and-patient-education-on-actinic-keratoses/20132/During skin checks, it's important for dermatologists to educate patients, especially younger ones, about the extent of sun damage and the benefits of field treatments. Anthony Rossi, MD and Vishal Patel, MD discuss their approaches.Ask an Expert: What's the Role for Infliximab in HS?
https://practicaldermatology.com/topics/general-topics/ask-an-expert-whats-the-role-for-infliximab-in-hs/19671/Evidence shows that infliximab, with its weight-based dosing, can be effective for hidradenitis suppurative. Steven Cohen, MD discusses the data and practical considerations with host Adam Friedman, MD.